Thermo Fisher Scientific Sells Microbiology Business to Astorg
Thermo Fisher Scientific Inc. has signed a definitive agreement to sell its microbiology business to Astorg for approximately $1.075 billion. The microbiology business specializes in antimicrobial susceptibility testing and culture media solutions for various sectors, including clinical, pharmaceutical, and food.
WALTHAM, Mass.–(BUSINESS WIRE)–Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion, consisting of cash and a $50 million seller note. The microbiology business provides antimicrobial susceptibility testing and culture media solutions for clinical, pharmaceutical and food